A carregar...
Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
In the last three years, five novel treatments have been shown to improve survival in metastatic castration-resistant prostate cancer (CRPC). These novel treatments have distinct mechanisms of action: tubulin-binding chemotherapy (cabazitaxel); immunotherapy (sipuleucel-T); CYP-17 inhibition (abirat...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891292/ https://ncbi.nlm.nih.gov/pubmed/24489604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287213509677 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|